论文部分内容阅读
目前抗痨方案中常用的利福平、毗嗪酞胺对肝脏损害发生率较高，尤其对合并乙肝病人，可能更为不利。我科近几年收治结核病患者中合并有乙型肝炎或肝炎后肝硬化患者34例，经抗痨治疗痊愈。对象方法本院近5年共收治合并有慢性乙型肝炎或肝炎后肝硬化的结核病患者34例，男性28例，
Rifampicin currently used in anti-tuberculosis programs, adjacent to azadirachtin a higher incidence of liver damage, especially for patients with hepatitis B may be more negative. In recent years, our department has received tuberculosis patients with hepatitis B or hepatitis cirrhosis in 34 patients, cured by anti-tuberculosis treatment. Object method Hospital in the past 5 years were treated with chronic hepatitis B or hepatitis cirrhosis in 34 cases of tuberculosis patients, 28 males,